Home » Topics » Gastrointestinal, BioWorld Science

Gastrointestinal, BioWorld Science
RSS

Orphan Medical's medicated chewing gum reduces stomach levels of H. pylori

May 9, 1997

Tanabe licenses T-0632 to Zeria

May 8, 1997

Neose Technologies initiates phase II trials with antiulcer drug

May 8, 1997

Preliminary clinical results for Lexirin

May 8, 1997

Maxim starts clinical trial of Maxamine in hepatitis C

May 8, 1997

Kaneka discloses anti-H. pylori rifamycins

May 6, 1997

Prokinetic agents from Kyorin

May 6, 1997

Positive results from preclinical studies with darifenacin

May 5, 1997

Positive preclinical results for T-330 in animal models of gastric ulcers

April 30, 1997

BMS-200475: profile of a novel anti-hepatitis B compound

April 30, 1997

Popular Stories

Today's news in brief
BioWorld
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...